Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CamAPS FX

K-Number: K232603 · 2024-05-23

ApplicantCamdiab , Ltd.
Decision Date2024-05-23
Product CodeQJI
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

CamAPS FX is a medical device manufactured by Camdiab , Ltd.. It received FDA 510(k) clearance on 2024-05-23 under approval number K232603. The device is classified under product code QJI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CamAPS FX?

CamAPS FX is a medical device that received FDA 510(k) clearance on 2024-05-23. It is manufactured by Camdiab , Ltd.. The 510(k) number is K232603.

When was CamAPS FX approved by the FDA?

CamAPS FX received FDA 510(k) clearance on 2024-05-23, under approval number K232603.

What company makes CamAPS FX?

CamAPS FX is manufactured by Camdiab , Ltd..

What is the FDA product code for CamAPS FX?

The FDA product code for CamAPS FX is QJI.

Related Devices (Code: QJI)

DEN190034Control-IQ TechnologyTandem Diabetes Care, Inc. K200467Control-IQ TechnologyTandem Diabetes Care, Inc. K220394SmartAdjust(TM) technologyInsulet Corporation K203774SmartAdjust technologyInsulet Corporation K232382Control-IQ TechnologyTandem Diabetes Care, Inc. K232224iLet® Dosing Decision SoftwareBeta Bionics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑